Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cheng-Han Lee

Showing results (301-310 of 350) with videos related to

Pageof 35
Sort By:
Translational Oncology|November 7, 2025
Establishment and characterization of preclinical models of human gynecologic tract carcinosarcomas demonstrates targetable FGFR1 alterationsNelson K Y Wong, Marta Llaurado Fernandez, Hannah Kim, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 17, 2017
BCOR is a robust diagnostic immunohistochemical marker of genetically diverse high-grade endometrial stromal sarcoma, including tumors exhibiting variant morphologySarah Chiang, Cheng-Han Lee, Colin J R Stewart, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 9, 2019
Integrated Molecular Analysis of Undifferentiated Uterine Sarcomas Reveals Clinically Relevant Molecular SubtypesAmrei Binzer-Panchal, Elin Hardell, Björn Viklund, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 9, 2016
Loss of switch/sucrose non-fermenting complex protein expression is associated with dedifferentiation in endometrial carcinomasAnthony N Karnezis, Lien N Hoang, Mackenzie Coatham, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|February 4, 2022
Effect of CYP2C19 status on platelet reactivity in Taiwanese acute coronary syndrome patients switching to prasugrel from clopidogrel: Switch StudyFeng-Yu Kuo, Cheng-Han Lee, Wei-Ren Lan, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 14, 2023
High-Grade Endometrial Stromal Sarcomas With YWHAE::NUTM2 Gene Fusion Exhibit Recurrent CDKN2A Alterations and Absence of p16 Staining is a Poor Prognostic MarkerFelix K F Kommoss, Lisa-Marie Mar, Brooke E Howitt, et al.
The Journal of Pathology|October 17, 2014
Identification of a novel FN1-FGFR1 genetic fusion as a frequent event in phosphaturic mesenchymal tumourJen-Chieh Lee, Yung-Ming Jeng, Sheng-Yao Su, et al.
Acta Cardiologica Sinica|January 23, 2023
Referral, Diagnosis, and Pharmacological Management of Peripheral Artery Disease: Perspectives from TaiwanJen-Kuang Lee, I-Chang Hsieh, Chun-Hung Su, et al.
The American Journal of Surgical Pathology|September 18, 2012
Cyclin D1 as a diagnostic immunomarker for endometrial stromal sarcoma with YWHAE-FAM22 rearrangementCheng-Han Lee, Rola H Ali, Marjan Rouzbahman, et al.
Gynecologic Oncology|July 6, 2024
Preclinical 3D model screening reveals digoxin as an effective therapy for a rare and aggressive type of endometrial cancerPooja Praveen Kumar, DuPreez Smith, James Key, et al.
Pageof 35

Showing results (301-310 of 350) with videos related to

Sort By:
Pageof 35
Translational Oncology|November 7, 2025
Establishment and characterization of preclinical models of human gynecologic tract carcinosarcomas demonstrates targetable FGFR1 alterationsNelson K Y Wong, Marta Llaurado Fernandez, Hannah Kim, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 17, 2017
BCOR is a robust diagnostic immunohistochemical marker of genetically diverse high-grade endometrial stromal sarcoma, including tumors exhibiting variant morphologySarah Chiang, Cheng-Han Lee, Colin J R Stewart, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 9, 2019
Integrated Molecular Analysis of Undifferentiated Uterine Sarcomas Reveals Clinically Relevant Molecular SubtypesAmrei Binzer-Panchal, Elin Hardell, Björn Viklund, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 9, 2016
Loss of switch/sucrose non-fermenting complex protein expression is associated with dedifferentiation in endometrial carcinomasAnthony N Karnezis, Lien N Hoang, Mackenzie Coatham, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|February 4, 2022
Effect of CYP2C19 status on platelet reactivity in Taiwanese acute coronary syndrome patients switching to prasugrel from clopidogrel: Switch StudyFeng-Yu Kuo, Cheng-Han Lee, Wei-Ren Lan, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 14, 2023
High-Grade Endometrial Stromal Sarcomas With YWHAE::NUTM2 Gene Fusion Exhibit Recurrent CDKN2A Alterations and Absence of p16 Staining is a Poor Prognostic MarkerFelix K F Kommoss, Lisa-Marie Mar, Brooke E Howitt, et al.
The Journal of Pathology|October 17, 2014
Identification of a novel FN1-FGFR1 genetic fusion as a frequent event in phosphaturic mesenchymal tumourJen-Chieh Lee, Yung-Ming Jeng, Sheng-Yao Su, et al.
Acta Cardiologica Sinica|January 23, 2023
Referral, Diagnosis, and Pharmacological Management of Peripheral Artery Disease: Perspectives from TaiwanJen-Kuang Lee, I-Chang Hsieh, Chun-Hung Su, et al.
The American Journal of Surgical Pathology|September 18, 2012
Cyclin D1 as a diagnostic immunomarker for endometrial stromal sarcoma with YWHAE-FAM22 rearrangementCheng-Han Lee, Rola H Ali, Marjan Rouzbahman, et al.
Gynecologic Oncology|July 6, 2024
Preclinical 3D model screening reveals digoxin as an effective therapy for a rare and aggressive type of endometrial cancerPooja Praveen Kumar, DuPreez Smith, James Key, et al.
Pageof 35